Literature DB >> 1526007

Enzymatic sample hydrolysis and HPLC in a study of phylloquinone concentration in human milk.

W E Lambert1, L Vanneste, A P De Leenheer.   

Abstract

Phylloquinone (vitamin K) is essential to prevent hemorrhagic diseases in newborns. We were interested in determining the concentration of phylloquinone in human milk and in elucidating the factors that influence that concentration. Human milk contains lipid constituents encapsulated with phylloquinone in the fat globules. To eliminate the lipids, we combined sonication and an enzymatic treatment with lipase to prevent degradation by drastic hydrolysis. Despite the low phylloquinone concentrations and the procedure's complexity (lipase treatment, two HPLC steps, and an on-line thermoinduced postcolumn reduction followed by fluorescence detection), within-day and day-to-day CVs of 5.2% and 5.8% were obtained (n = 8, mean = 1.86 micrograms/L, and n = 7, mean = 1.74 micrograms/L, respectively). The mean concentration of phylloquinone in 126 samples was 1.15 +/- 0.82 micrograms/L (mean +/- SD); no correlation was observed between the vitamin concentration and the postpartum date of collection. There was a positive correlation between phylloquinone concentration and phospholipid and cholesterol content (r = 0.5578 and 0.6020, respectively).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526007

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

Review 1.  Micronutrients in Human Milk: Analytical Methods.

Authors:  Daniela Hampel; Daphna K Dror; Lindsay H Allen
Journal:  Adv Nutr       Date:  2018-05-01       Impact factor: 8.701

2.  Adulthood obesity is positively associated with adipose tissue concentrations of vitamin K and inversely associated with circulating indicators of vitamin K status in men and women.

Authors:  M Kyla Shea; Sarah L Booth; Caren M Gundberg; James W Peterson; Catherine Waddell; Bess Dawson-Hughes; Edward Saltzman
Journal:  J Nutr       Date:  2010-03-17       Impact factor: 4.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.